- Report
- May 2024
- 135 Pages
Global
From €5893EUR$6,499USD£4,963GBP
- Report
- May 2024
- 129 Pages
Global
From €5893EUR$6,499USD£4,963GBP
- Report
- May 2024
- 130 Pages
Global
From €5893EUR$6,499USD£4,963GBP
- Report
- May 2023
- 132 Pages
India
From €2719EUR$2,999USD£2,290GBP
- Report
- April 2024
- 136 Pages
Global
From €2719EUR$2,999USD£2,290GBP
- Report
- June 2023
- 116 Pages
Global
From €4080EUR$4,500USD£3,437GBP
- Report
- June 2023
- 115 Pages
Global
From €4080EUR$4,500USD£3,437GBP
- Report
- October 2022
- 120 Pages
Global
From €4080EUR$4,500USD£3,437GBP
- Report
- August 2022
- 104 Pages
Global
From €4080EUR$4,500USD£3,437GBP
- Report
- August 2022
- 116 Pages
Global
From €4080EUR$4,500USD£3,437GBP
- Report
- August 2022
- 120 Pages
Global
From €4080EUR$4,500USD£3,437GBP
- Report
- July 2022
- 131 Pages
Global
From €4080EUR$4,500USD£3,437GBP
- Report
- November 2021
- 120 Pages
Global
From €4080EUR$4,500USD£3,437GBP
- Report
- October 2021
- 100 Pages
Global
From €4080EUR$4,500USD£3,437GBP
- Report
- September 2021
- 99 Pages
Global
From €4080EUR$4,500USD£3,437GBP
From €2698EUR$2,975USD£2,272GBP
€3174EUR$3,500USD£2,673GBP
- Report
- February 2025
- 85 Pages
India
From €2698EUR$2,975USD£2,272GBP
€3174EUR$3,500USD£2,673GBP
- Report
- December 2024
- 85 Pages
India
From €2698EUR$2,975USD£2,272GBP
€3174EUR$3,500USD£2,673GBP
- Report
- February 2024
- 182 Pages
Global
From €3468EUR$3,825USD£2,921GBP
€4080EUR$4,500USD£3,437GBP
- Report
- February 2024
- 112 Pages
Middle East, Africa
From €4307EUR$4,750USD£3,628GBP

The Endocrine and Metabolic Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat endocrine and metabolic disorders. Endocrine disorders are conditions that affect the body's hormones, while metabolic disorders are conditions that affect the body's ability to process and use energy. Endocrine and metabolic disorders can include diabetes, thyroid disorders, obesity, and adrenal disorders.
Endocrine and Metabolic Disorders Drugs are typically developed by pharmaceutical companies and are prescribed by physicians. These drugs can be used to treat a variety of endocrine and metabolic disorders, including diabetes, thyroid disorders, obesity, and adrenal disorders. Common drugs used to treat these conditions include insulin, metformin, and glucagon-like peptide-1 (GLP-1) agonists.
Some of the major companies in the Endocrine and Metabolic Disorders Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, production, and marketing of drugs used to treat endocrine and metabolic disorders. Show Less Read more